Clinical Report: Toll-like Receptors in Infectious Myocarditis

Overview

This review discusses the role of Toll-like receptors (TLRs) in infectious myocarditis, highlighting their involvement in pathogen recognition and disease progression.

Background

Infectious myocarditis is a severe inflammatory condition of the heart that can lead to significant morbidity and mortality. Understanding the mechanisms of TLRs in this context is crucial, as they play a central role in the immune response to various pathogens. The heterogeneity in clinical presentation and outcomes necessitates a deeper exploration of TLR dynamics.

Data Highlights

Key Findings

• TLRs are critical in recognizing pathogens and initiating inflammatory responses in infectious myocarditis.
• The in-hospital mortality rates for COVID-19 and influenza-associated myocarditis differ significantly.
• Pathogen-TLR matching influences the inflammatory phenotype and severity of myocarditis.
• Current studies often overlook the spatiotemporal dynamics of TLR signaling during disease progression.

Clinical Implications

Healthcare professionals should consider the role of TLRs in the pathogenesis of infectious myocarditis when evaluating patients.

Conclusion

The review provides a comprehensive understanding of TLRs in infectious myocarditis.

Related Resources & Content

1. Frontiers in Cardiovascular Medicine, 2026 -- Myocardial inflammation in myocarditis: mechanisms and therapeutic targets
2. Clinical Research in Cardiology, 2009 -- Imaging Techniques for Non-Invasive Diagnosis of Acute Viral Myocarditis
3. Clinical Research in Cardiology, 2024 -- The Role of Endomyocardial Biopsy in Myocarditis Patients: Is It Still Relevant in the Era of Cardiac Magnetic Resonance Imaging?
4. Basic Research in Cardiology, 2026 -- Dissecting myocardial and systemic drivers of cardiac dysfunction in the murine CVB3 myocarditis model using microRNA-guided viral detargeting
5. ESC Guidelines, 2025 -- Essential Messages for Myopericardial Spectrum
6. PubMed, 2009 -- Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study
7. PMC, 2023 -- A Comparison of COVID-19 and Influenza-Associated Myocarditis: A Nationwide Study in the United States
8. https://www.escardio.org/static-file/Escardio/Guidelines/Products/Essential%20Messages/2025%20Gls/2025%20Essential%20Messages_MyoPeri.pdf
9. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study - PubMed
10. A Comparison of COVID-19 and Influenza-Associated Myocarditis: A Nationwide Study in the United States - PMC